CEACAM5 and colorectal carcinoma: Carcinoembryonic antigen (CEA) is the most commonly used serum biomarker for CRC, but its sensitivity ranges from 35 to 75 % at the standard threshold of 3.08 g/L, and is especially poor for early-stage CRC (20–60 %) [8,9].